Description
LuciDarax 100mg is a prescription tablet containing daraxonrasib, a targeted oral medicine for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib is a RAS(ON) multi selective inhibitor, a newer class of cancer medicine that blocks the RAS proteins driving tumor growth. It must be used under the supervision of a qualified oncologist.
What Is LuciDarax 100mg Used For?
Daraxonrasib is used for metastatic pancreatic adenocarcinoma in adults. In the United States, the FDA approved daraxonrasib (sold as Rasonque) on August 26, 2026 for patients whose cancer has progressed after at least one earlier systemic therapy, or who cannot receive multi drug treatment. Your oncologist decides whether it suits your situation.
How Does Daraxonrasib Work?
Mutated RAS proteins drive most pancreatic cancers. Daraxonrasib binds a protein called cyclophilin A, and this complex then attaches to RAS in its active (ON) state and blocks the growth signals it sends. It is designed to cover several common RAS mutations, including G12, G13 and Q61 variants, rather than a single one.
Clinical Results: What the RASolute 302 Trial Found
The phase 3 RASolute 302 trial compared daraxonrasib with standard chemotherapy in 500 previously treated adults.
| Measure | Daraxonrasib | Chemotherapy |
|---|---|---|
| Median overall survival | 13.2 months | 6.7 months |
| Median progression free survival | 7.2 months | 3.6 months |
| Overall response rate | 30% | 11% |
Read our full daraxonrasib guide for a plain language summary, or see the FDA approval summary.
Dosage and How to Take It
Daraxonrasib is taken by mouth once daily until the disease progresses or side effects become unacceptable. Your oncologist sets your exact dose and the number of tablets. The FDA labelled dose for the approved US brand is 300 mg once daily. Never change your dose without medical advice.
Common Side Effects
The most common side effects reported are rash, diarrhea, mouth inflammation, nausea, vomiting, fatigue, abdominal pain, swelling, reduced appetite and bleeding. Contact your doctor early if any of these become severe or persistent, as many can be managed with supportive care.
Before You Start
Tell your doctor about all medicines and supplements you take and about any other health conditions. Store the tablets in the original pack, away from heat, moisture and children.
Product Details
| Product | LuciDarax 100mg |
| Active ingredient | Daraxonrasib 100 mg |
| Drug class | RAS(ON) inhibitor, targeted therapy |
| Form | Oral tablets |
| Manufacturer | [add verified manufacturer] |
| Pack size | [add pack size] |
| Prescription | Required |
Frequently Asked Questions
What is LuciDarax 100mg?
LuciDarax 100mg is an oral tablet containing daraxonrasib, a RAS inhibitor used for metastatic pancreatic cancer in adults.
Is daraxonrasib chemotherapy?
No. It is a targeted therapy. Chemotherapy affects fast dividing cells broadly, while daraxonrasib blocks the RAS signalling that drives tumor growth.
Is a prescription needed?
Yes. A valid prescription from a qualified doctor is required. See our prescription policy.
How often is daraxonrasib taken?
Once daily by mouth, as directed by your oncologist.
What are the common side effects?
Rash, diarrhea, mouth inflammation, nausea, vomiting and fatigue are the most common.
Questions about this product? Contact our pharmacy team or browse more oncology medicines.
Reviews
There are no reviews yet.